Literature DB >> 21934492

Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.

Peizeng Yang1, Min Sun.   

Abstract

PURPOSE: To determine the incidence and characterize the clinical features of band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada (VKH) syndrome.
METHODS: The data of 360 consecutive VKH patients examined from November 2000 to December 2008 were reviewed. The patients were diagnosed with VKH syndrome according to international criteria. The data of VKH patients with band-shaped keratopathy, including age at disease onset, gender, intervals between disease onset and emergence of this complication, other complications, and therapy were collected and analyzed.
RESULTS: Of the 360 VKH patients, 66 patients (132 eyes) visited us at the stage of posterior uveitis or anterior uveal involvement. None of these 132 eyes had band-shaped keratopathy develop. The other 294 VKH patients (587 eyes) visited us at the stage of recurrent, granulomatous, anterior uveitis, and band-shaped keratopathy was observed in 21 eyes of 13 patients (3.6%). Of these 13 patients, there were 6 men and 7 women. Band-shaped keratopathy in 21 eyes was observed from 9 months to 32 years, with a mean of 12.7 years after the first uveitis attack. These patients had been intermittently treated with systemic corticosteroids and occasionally in combination with a transient use of either chlorambucil or azathioprine. All the eyes with band-shaped keratopathy showed recurrent and chronic intraocular inflammation. Complicated cataract, increased intraocular pressure and decreased intraocular pressure were observed in 18, 12, and 5 eyes, respectively. Ocular phthisis was observed in 1 eye. The best-corrected vision of 0.3 or less was observed in 85.1% of the affected eyes.
CONCLUSIONS: Band-shaped keratopathy is a relatively uncommon complication in VKH syndrome and mostly occurs in relatively younger patients with a long course of chronic intraocular inflammation. It was frequently associated with complicated cataract and secondary glaucoma and was a marker for poor visual outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934492     DOI: 10.1097/ICO.0b013e31820f774c

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  5 in total

Review 1.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

2.  Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy.

Authors:  Shizhao Yang; Tianyu Tao; Zhaohao Huang; Xiuxing Liu; He Li; Lihui Xie; Feng Wen; Wei Chi; Wenru Su
Journal:  Front Med (Lausanne)       Date:  2022-01-12

3.  Systemic glucocorticoid-free therapy with adalimumab plus immunosuppressants versus conventional therapy in treatment-naïve Vogt-Koyanagi-Harada disease patients.

Authors:  Shizhao Yang; Tianyu Tao; Zhaohuai Li; Binyao Chen; Zhaohao Huang; Xiuxing Liu; He Li; Lihui Xie; Wen Feng; Wenru Su
Journal:  Ann Transl Med       Date:  2022-06

4.  Clinical profile and demographic distribution of band shaped keratopathy in India: A study of 8801 patients.

Authors:  Anthony V Das; Lalitha N Pillutla; Sunita Chaurasia
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

Review 5.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.